Search

Search the current U.S. Code within Title 21

Search by citation or keyword across the current edition within Title 21.

20 results 379j-12
Scoped to Title 21
Exact match Title 21 Title 21 / Chapter 9 FEDERAL FOOD, DRUG, AND COSMETIC ACT / Subchapter VII GENERAL AUTHORITY / Part C Fees / Subpart 4 fees relating to animal drugs / Section 379j–12

21 U.S.C. § 379j–12

Authority to assess and use animal drug fees

Part C Fees / Subpart 4 fees relating to animal drugs

Exact citation match for 21 USC § 379J-12

Title 21 Title 21 / Section 379j–11

21 U.S.C. § 379j–11

Definitions

Part C Fees / Subpart 4 fees relating to animal drugs

Definitions

Title 21 Title 21 / Section 360ddd–2

21 U.S.C. § 360ddd–2

Inapplicability of drug fees to designated medical gases

Subchapter V DRUGS AND DEVICES / Part G Medical Gases

Inapplicability of drug fees to designated medical gases

Title 21 Title 21 / Section 301

21 U.S.C. § 301

Short title

Chapter 9 FEDERAL FOOD, DRUG, AND COSMETIC ACT / Subchapter I SHORT TITLE

Short title

Title 21 Title 21 / Section 379j–42

21 U.S.C. § 379j–42

Authority to assess and use human generic drug fees

Part C Fees / Subpart 7 fees relating to generic drugs

Authority to assess and use human generic drug fees

Title 21 Title 21 / Section 379j–72

21 U.S.C. § 379j–72

Authority to assess and use OTC monograph fees

Part C Fees / Subpart 10 fees relating to over-the-counter drugs

Authority to assess and use OTC monograph fees

Title 21 Title 21 / Section 379j–62

21 U.S.C. § 379j–62

Authority to assess and use outsourcing facility fees

Part C Fees / Subpart 9 fees relating to outsourcing facilities

Authority to assess and use outsourcing facility fees

Title 21 Title 21 / Section 379j–21

21 U.S.C. § 379j–21

Authority to assess and use generic new animal drug fees

Part C Fees / Subpart 5 fees relating to generic new animal drugs

Authority to assess and use generic new animal drug fees

Title 21 Title 21 / Section 379j–31

21 U.S.C. § 379j–31

Authority to collect and use fees

Part C Fees / Subpart 6 fees related to food

Authority to collect and use fees

Title 21 Title 21 / Section 379j–41

21 U.S.C. § 379j–41

Definitions

Part C Fees / Subpart 7 fees relating to generic drugs

Definitions

Title 21 Title 21 / Section 379j–51

21 U.S.C. § 379j–51

Definitions

Part C Fees / Subpart 8 fees relating to biosimilar biological products

Definitions

Title 21 Title 21 / Section 379j–52

21 U.S.C. § 379j–52

Authority to assess and use biosimilar biological product fees

Part C Fees / Subpart 8 fees relating to biosimilar biological products

Authority to assess and use biosimilar biological product fees

Title 21 Title 21 / Section 379j–71

21 U.S.C. § 379j–71

Definitions

Part C Fees / Subpart 10 fees relating to over-the-counter drugs

Definitions

Title 21 Title 21 / Section 379j–73

21 U.S.C. § 379j–73

Reauthorization; reporting requirements

Part C Fees / Subpart 10 fees relating to over-the-counter drugs

Reauthorization; reporting requirements

Title 21 Title 21 / Section 2251

21 U.S.C. § 2251

Jurisdiction; authorities

Chapter 27 FOOD SAFETY MODERNIZATION / Subchapter IV MISCELLANEOUS PROVISIONS

Jurisdiction; authorities

Title 21 Title 21 / Section 393

21 U.S.C. § 393

Food and Drug Administration

Chapter 9 FEDERAL FOOD, DRUG, AND COSMETIC ACT / Subchapter X MISCELLANEOUS

Food and Drug Administration

Title 21 Title 21 / Section 399

21 U.S.C. § 399

Grants to enhance food safety

Chapter 9 FEDERAL FOOD, DRUG, AND COSMETIC ACT / Subchapter X MISCELLANEOUS

Grants to enhance food safety

Title 21 Title 21 / Section 352

21 U.S.C. § 352

Misbranded drugs and devices

Subchapter V DRUGS AND DEVICES / Part A Drugs and Devices

Misbranded drugs and devices

Title 21 Title 21 / Section 355

21 U.S.C. § 355

New drugs

Subchapter V DRUGS AND DEVICES / Part A Drugs and Devices

New drugs

Title 21 Title 21 / Section 355h

21 U.S.C. § 355h

Regulation of certain nonprescription drugs that are marketed without an approved drug application

Subchapter V DRUGS AND DEVICES / Part A Drugs and Devices

Regulation of certain nonprescription drugs that are marketed without an approved drug application